Background: Surgery is the cornerstone of treatment for many solid tumours. A wide variety of imaging modalities are available before surgery for staging, although surgeons still rely primarily on visual and haptic cues in the operating environment. Image and molecular guidance might improve the adequacy of resection through enhanced tumour definition and detection of aberrant deposits. Intraoperative modalities available for image-and molecular-guided cancer surgery are reviewed here.
Introduction
In recent decades, multiple imaging modalities have emerged as essential tools in cancer diagnostics, providing information about the molecular and functional processes in normal and diseased tissues 1 . New technologies have been developed to enhance understanding of the diversity and behaviour of cancer in vivo 2 . Despite these resources, surgeons still primarily rely on their eyes and hands as tools during surgery 3 -5 . In oncological surgery, clean and clear demarcation of the tumour boundaries is pivotal to determining the balance between excising too little or too much tissue. Therefore, careful examination of the tumour borders is essential 6, 7 . Preoperative imaging does not always correlate well with intraoperative images owing to tumour growth, deformation of soft tissue, shifting of organs, or misalignment of the image display compared with the surgical field 8 .
As Rosenthal and colleagues 9 discussed for patients with breast, melanoma or head-neck cancer, surgical excision requires three detection steps: initial assessment before resection; initial assessment during incision, including detection of regional metastasis as well as lymph nodes; and postresection margin analysis by the pathologist. Eyes and hands cannot detect the exact boundaries of a tumour, or create a clear three-dimensional (3D) morphological or functional overview of the operative site 5 . As a result, histological tumour involvement of the resection margins may be observed at least 20 per cent of the time in patients with breast cancer 3, 4, 9, 10 . To improve cure and complication rates, the use of intraoperative in vivo and real-time tools would be useful. To achieve this requires better spatial resolution than can be achieved by the human eye, minimal interference with daily practice, and operator-friendly instrumentation that is time efficient 11 . To go beyond visualization of anatomical boundaries, real-time molecular information would provide additional information to optimize surgical resection. The focus of this review was intraoperative modalities for image-and molecular-guided cancer surgery.
Methods
Twenty-five characteristics were selected to evaluate and compare the ten different image-guided surgery modalities reviewed here. As stated by Weissleder and Pittet 2 : 'for imaging technologies to be adapted more widely and to be complementary to other types of imaging the read-outs need to meet certain criteria; they need to be quantitative, high resolution, longitudinal, comprehensive, standardized, digital and sensitive'. This statement refers to cancer imaging in general, but the requirements apply equally well to image-and molecular-guided surgery in patients with cancer 2 .
The chosen characteristics are based on relevant articles, which were found through PubMed searches (January 2012-January 2017) using one or more of the following keywords: 'surgery', 'cancer', 'oncology' and the specific names of the (imaging) modalities. Further searches were carried out for specific performance characteristics, such as resolution. Abstracts were reviewed and full-text articles obtained where possible. References and linked articles from included papers were studied to identify further relevant information.
To summarize the data in a comparable way, a three-point rating was applied to quantitate image-guided surgery characteristics. User friendliness was determined from discussions with end-users but differed from user to user; these were scored as easy (+), intermediate (-/+) or challenging (-).
Results
The study identified ten modalities that could be used for image guidance during surgery. Examples of imaging systems for each modality, along with a representative clinical image, are shown in Figs 1-3 . In general, the modalities 12 and d small γ camera 13 can be classified into four groups: conventional, optical, nuclear and endogenous reflectance. Table 1 provides information on conventional modalities already familiar to many practitioners; the imaging modalities are described along with the type of information obtained together with the surgical interference and associated risks. Tables 2 and 3 provide the same information for optical and nuclear, and endogenous reflectance techniques respectively. The same groupings are used for Tables [4] [5] [6] , which compare the performance of each modality during surgery, including the criteria that Weissleder and Pittet 2 mention as being essential. Tables 4-6 additionally provide information about the clinical potential and major challenges for clinical implementation of each of the ten modalities.
Comparison between modalities
Modalities within each group are compared in the tables, and it is also possible to compare techniques between groups across tables. Fig. 4 provides a comparison of all ten modalities based on the characteristics most interesting in clinical practice: penetration depth, resolution and acquisition. This clearly demonstrates a common trade-off in image-guided surgery -greater penetration depth often coincides with degradation of resolution.
Conventional modalities
The use of non-invasive imaging for disease diagnosis has become a standard operating procedure, and these conventional modalities are widely available. The current standard consists of conventional imaging modalities that yield anatomical and macroscopic structural information. The images and information obtained with any new technologies must be compared with those from these established techniques 64 .
Intraoperative MRI
To be able to use MRI during surgery, the magnetic resonance compatibility of surgical equipment needs to be guaranteed, together with special policies for safety and staff training. The implementation of such policies can be prohibitively expensive, although the costs are dependent on the field strength of the system. High-field systems (more than 1⋅0 T) require far more investment as shielding of the operating room is essential, but provide high-resolution images within a shorter acquisition time. Low-field systems (below 0⋅3 T) are cheaper as no additional requirements for the operating theatre are necessary, and they can be integrated into existing operating rooms 22 . Another advantage of using a low-field system is the availability of open systems, which are more useful during surgery. Nevertheless, the lower the field strength, the lower the image quality or the longer the acquisition time 19, 25 .
Despite these limitations, the main reason for still making use of MRI in neurosurgery is that the maximum amount of tumour can be removed in a safe manner 25 .
Intraoperative CT
In general, CT offers high throughput with highresolution imaging; however, this is not the case when Fig. 3 Endogenous reflectance image-guided surgery systems and examples of image output: a Raman spectroscopy 14 , b optical coherence tomography and c rapid evaporative ionization mass spectrometry 15 it is used for intraoperative imaging. Acquiring CT images during surgery takes 10-15 min, partly owing to the interference caused by the shape of the gantry, as using a bore will cause more interference than use of a C-arm. For assessing surgical specimens instead of the cavity, micro-CT can be used as there is less interference with the procedure and a high spatial resolution of less than 1 μm. Nevertheless, the accuracy of margin assessment is variable owing to specimen orientation, and there can be a high rate of non-specific findings due to dense parenchyma and architectural distortion resulting from the surgery 20 .
Intraoperative ultrasonography
Of the conventional imaging modalities, ultrasonography is the easiest to incorporate during surgery as it does not interfere with the procedure or present logistical challenges, gives real-time information and surgeons are already used to interpreting the images obtained. In addition, intraoperative ultrasonography is one of the most sensitive imaging modalities for assessing small lesions as a high-frequency transducer can be used. In addition to sensitivity, the specificity of discrimination between healthy tissue and residual disease is a benefit of this technique 27 . Because intraoperative ultrasonography can be used in an iterative mode, one should be aware of an essential drawback, that surgical manipulation can cause artefacts so the image quality will decrease as the operation proceeds 23 .
Optical imaging
Optical imaging techniques such as fluorescence-guided surgery (FGS) and multispectral optoacoustic tomography (MSOT) can provide real-time feedback with limited workflow disruption. They require a targeted probe that consists of a fluorophore in the near-infrared window (approximately 700-900 nm) which has the largest penetration depth of optical light in tissue. In this window, penetration is 1 cm for FGS or a few centimetres with MSOT, compared with only a couple of millimetres for wavelengths below 700 nm 3, 4, 6, 38 . There is also a window above 900 nm, the so-called second-window near-infrared light (NIR2), ranging from 900 to 1450 nm. This window has the advantages of even deeper tissue penetration and low tissue autofluorescence signals, which lead to higher tumour to background ratios. In vivo testing in experimental studies has shown a penetration depth of up to 18 mm, and simulations suggest that this might be increased to up to 10 cm 65 -67 . To make use of this NIR2 Structural differences owing to differences in absorbance 17, 20 Contrast is based on scattering/reflectance differences between different types of tissue: soft tissue, fat and fluid 18 24, 27 . Delay is dependent on operator (maximum a few minutes) 23 Interference with surgery Yes, highly interfering. Positionwise may even be impossible 22 Yes, depending on the modality and the possibility of a sliding gantry on a railtrack 24, 26 Not in general and presents no logistical challenges 23 19, 22, 25 No complications or infections related to intraoperative CT and surgical complications directly recognized 26 Relatively safe and well tolerated 27 . It gives direct feedback to the surgeon 32 2D, two-dimensional; 3D, three-dimensional.
window, new instrumentation is required. Specific probes for use in this range go beyond the scope of this review; however, single-walled carbon nanotubes or upconversion nanoparticles are encouraging opportunities 65 -67 .
Fluorescence-guided surgery
FGS has the advantage of providing real-time imaging, being relatively cheap and user friendly, and not interfering with the surgical area. However, it also has several disadvantages, such as the limited penetration depth (maximum 1 cm), and challenges in quantification owing to other processes associated with the use of light, such as photobleaching, transmission and reflection changes. Light in general is attenuated by absorption and scatter in tissue; the total attenuation (sum of attenuation from absorption and scatter) has an exponential relationship with depth. Practically, this means that fewer than 0⋅0001 per cent of the photons transmitted into tissue can be detected and, of this amount, only 10-25 per cent of the photons generated in tissue will really be recovered. This is due to the relatively small quantum yield of most fluorophores and especially near-infrared fluorophores. Other limitations for quantification are absorption and scatter as these characteristics are highly variable in tissue. Full correction, by measurement of the absorption, scatter and anisotropy of tissue, can lead to quantitative measurements; however, this is still in its infancy 3 . Another limitation to full clinical translation is the lack of specific contrast agents. So far only three tumour-specific agents have been registered for clinical use. Several other tumour-specific agents are in the process of clinical translation, but this is dependent on the fluorophore being approved 3 .
Multispectral optoacoustic tomography
In general, MSOT has the same advantages and disadvantages as FGS, except that it has a greater penetration Charged particles emitted from radionuclides transfer energy as they move through a medium. If the particles are travelling faster than the speed of light in that medium, the transferred energy is released, through relaxation, as light 33 Radionuclides introduced to the patient emit γ radiation. γ photons have sufficient energy to pass relatively unimpeded through tissue to be detected by an external camera 34 Type of information Presence of a fluorophore or specific tissue properties in a certain area 6, 9 Differences in optical absorption inside tissue are visualized 11 Functional images based on the distribution of an externally administered particle-emitting radiotracer 35 Quantitative functional images based on the distribution of an externally administered γ-emitting radiotracer 36 Anatomical information No; however, autofluorescence provides information about tissue properties 9 Yes, by strong endogenous absorbers like blood and melanin 11 depth. In addition, both FGS and MSOT are based on photon delivery, but low-frequency ultrasonic pulses are also detected in optoacoustic tomography. These pulses are generally unaffected by tissue absorption and scattering, essentially removing a large component of the limiting factor in the development of quantitative methods for fluorescence-based imaging at depth. Given that the strength of an optoacoustic signal within a pixel is a function of both the diffusive light reaching that pixel and the concentration of absorber present, it is apparent that the concentration of a local chromophore can be determined by measuring or modelling light propagation through the tissue. Recent work by Tzoumas and colleagues 61, 62 and
Brochu and co-workers 63 has demonstrated that this result can be achieved both in phantoms and, more importantly, in vivo, giving a glimpse that quantitation is a possibility in clinical optoacoustic tomography.
Nuclear imaging
Nuclear modalities use a radioactive tracer to generate images, with a high sensitivity and specificity in general, although this is dependent on the tracer of choice 55 . However, the use of radioactive material requires special biosafety permits, additional training, and safety procedures for both personnel and patients.
Image-and molecular-guided surgery e75 Cross-sectional images are generated, mimicking the intensity of optical backscatter of light passed through tissue 43 Identification is based on use of tissue-specific libraries (molecular profiles or fingerprints) to identify the tissue type 45 
Anatomical information
Yes, depending on technique 41 Yes 21, 43 , tomographic images of biological tissue are generated (morphology) 11, 41, 46 No, it is based on tissue-specific molecular signatures 47 2D/3D 2D, 3D is possible by using stacked images or measuring at a different depth 2D and 3D depending on detector used 44 A spectrum is generated, not an image 15, 48, 49 Need for contrast agent No, it is a label-free method as it uses intrinsic properties of molecules 42 No, depends on optical scattering and reflectance of tissue to generate contrast 41, 44, 46 No, it is a label-free technique 15, 48, 49 Cost (machine and facility) € € €€ 47 Acquisition cost € € € Time (acquisition and reconstruction) Short (1-10 min) 41 Relatively safe; similar to ultrasonography and rapid image acquisition 21, 43 Relatively safe 45 . For the mass analyser system, European norms have to be complied with 2D, two-dimensional; 3D, three-dimensional.
Cherenkov luminescence imaging
Cherenkov luminescence imaging (CLI) is actually a combination of optical and nuclear imaging as the radioactive tracer in CLI is used to create optical photons. A drawback of this is that CLI has a tissue penetration of only 1 cm, similar to that of optical imaging. On the other hand, the resolution is also similar to that of optical imaging, which is higher than that of any other nuclear imaging modality. Nevertheless, the intensity of the optical photons generated is about a billion times lower than the illumination in an operating theatre, which makes it hardly suitable for use during open surgery; endoscopic applications would be favourable 33 . This low light level negatively influences the sensitivity, which can be improved by injecting a larger amount of radioactivity. The amount of radioactivity correlates well with the light output (radiance), although an increase in radioactivity will also lead to an increase in radiation burden.
Small γ cameras
Like single-photon emission CT (SPECT), γ cameras can be considered a conventional modality. However, these systems face similar drawbacks to MRI and CT in that the size and shape of the machine causes a lot of surgical interference, and a dedicated scanning room is needed. To circumvent this, a handheld γ probe is already used in clinical practice for sentinel lymph node detection. Although useful, these probes can only indicate the amount of activity When to use during surgery Can be used for surgical (re)orientation and for quality control of resection cavity 19, 22, 25 Can be used for surgical (re)orientation, and micro-CT for lump margin assessment 20, 26 Used for real-time surgical guidance at all stages 23 Artefacts/ limitations Vascularized tumours and haematomas lead to poorly visualized operative fields as they produce imaging artefacts 22 Dense parenchyma and architectural distortion make margin assessment difficult 20 . Bone anatomy well visualized but limited on the lesion itself 54 . Radiation exposure 29 Cirrhosis and steatosis (induced by chemotherapy); imaging of cirrhotic or steatotic liver can be improved by using contrast agent 27, 28 . Lack of anatomical orientation 23 Sensitivity, specificity of system Increases with field strength 19, 25, 55 Specificity > 90%, but sensitivity only 60% 20 Sensitivity and specificity both high 27 FOV, field of view.
within their field of view and do not have imaging capabilities. Innovative radiation detector design has allowed the generation of compact γ cameras 68 . The difference between SPECT and use of small γ cameras is that with γ imaging the sensitivity is dependent on the tracer but independent of the depth of the tumour; for small γ cameras there is a trade-off between sensitivity and spatial resolution, depending on the imaging distance. In addition, the field of view is smaller but dependent on the detector design.
Endogenous reflectance
The final group of techniques encompasses a variety of endogenous reflectance/signals modalities. The advantage of this group is that no additional contrast agents are necessary to generate relevant and very detailed information based on the characteristics of the tissue itself. Nevertheless, creating high-resolution output may require substantial acquisition times.
Raman spectroscopy
In general, Raman spectroscopy uses the intrinsic properties of molecules to generate contrast, which means that is not limited to a certain tissue type, although it requires a more specialized approach for skin pigments such as in melanoma. To create additional contrast, plasmonic particles or organic polymers coupled with antibodies could be used. Stimulated Raman scattering can be used to monitor dynamic changes, alterations in tissue cellularity, axonal density and protein/lipid ratio 42 . A possible limitation of translating Raman spectroscopy into clinical practice is the question of how small fields of view could be applied to the validation of a tumour bed, which is relatively large. A clinical trial 42 using this technique detected low-grade gliomas instead of the tumour bed. For this, an image-resect-image technique was used in which the arm movement was predefined. This method led to an additional operating time of 10 min for image acquisition, which was not considered obstructive to surgical workflow 41, 42 .
Image-and molecular-guided surgery e77 Use similar to fluorescence-guided surgery but with more anatomical information 11, 58 Mostly used for quality control of resection cavity and lump assessment 12, 33 Used for SLN detection, surgical orientation and for quality control of resection cavity 37, 59 Depth 1 cm 3, 4 Several centimetres 4 1 cm, depending on radiotracer used 33, 60 No limit 4 Interoperator Agents under investigation for fluorescence-guided surgery also likely to be studied for multispectral optoacoustic tomography 4 PET tracers clinically available but none specific to Cherenkov luminescence imaging; more tumour-specific tracers are in clinical development SPECT tracers clinically available but none specific to γ camera imaging; more tumour-specific tracers are in clinical development
Quantification of size/signal Only relative; absorption and scatter limit ability for absolute quantification 2 Yes, via amount of signal in an area 61 -63 Only relative; absorption and scatter limit ability for absolute quantification 33 Absolute or relative depending on camera design 2 Cancer type Primary tumour, lymph nodes, examination of vital structures, metastases 3 Broad range of solid tumours eventually examined via endoscopy 11 Broad range of solid tumours Numerous cancer types; SLN, parathyroid, colon 37 Artefacts/ limitations Attenuation correction of excitation light can help with target detection, although overcompensation can also cause false-positives 3 . Penetration depth 3, 38 Requires surface contact High radiation burden. Exclusion of ambient light is essential; endoscopic applications would be favourable 33 . Scattering can cause signal to be visualized in incorrect area 56 Radiation burden. Trade-offs between dose, acquisition time (sensitivity), spatial resolution and FOV Sensitivity, specificity of system Superficial tissue can be detected with high sensitivity. Sensitivity decreases with depth 4, 38 Nanomolar sensitivity with high specificity based on multispectral imaging
Lack of sensitivity owing to very low light levels 33 . Specificity dependent on tracer used 55 Increase in imaging distance degrades sensitivity and spatial resolution 34, 37 . Sensitivity and specificity dependent on system and tracer 55 FOV, field of view; SLN, sentinel lymph node; SPECT, single-photon emission CT.
Optical coherence tomography
Optical coherence tomography (OCT) has the advantage of being analogous to ultrasonography, which makes the images easy for surgeons to interpret as they are already familiar with such images. Instead of sound, OCT uses the reflections of light. This means that OCT does not need direct contact with the surgical area; however, owing to differences in refractive index, direct contact is desirable 11, 21, 46 . Similar to Raman spectroscopy, OCT does not require a contrast agent, but the agents used in optical Yes, but not on the same piece of tissue 45, 47 When to use during surgery Mostly for quality control of resection cavity and lump assessment 42 Mostly for quality control of resection cavity and lump assessment 41, 44 Mostly for quality control of resection cavity and lump assessment 45, 47 Depth Hundreds of micrometres 41, 42 0⋅2 cm 21, 41, 43, 44 Not applicable/limited
Interoperator variability Low, when incorporated in a robotics system
High/medium 44 Low as a reference library is used for feedback and tissue classification 15 User friendly +, When incorporated in a robotics system; otherwise low Bladder, prostate, kidney 21 , breast 43, 44 , melanoma, thyroid 44 , ovary 46 All solid tumours, e.g. breast, liver, colorectal, brain 15 Artefacts/ limitations Interrogate a small region of tissue. Signal to noise ratio can be a limiting factor. Intrinsic weak signals can be partly solved by use of high-quality instruments 41, 42 Limited penetration depth 21 . Optical scattering and coherent speckle artefacts from cellular structures limit visualization of small cells 43 Tissue needs to be disrupted for analysis and cannot be measured again 45 . Need for validated tissue-specific databases 15 Sensitivity, specificity of system Accuracy, sensitivity and specificity > 90% to distinguish normal brain from tumour-invaded brain 42 High, sensitivity rates between 80 and 100%, specificity 60-100% 11, 41, 44 High, > 90% depending on accuracy of classification library FOV, field of view.
imaging can be utilized to generate additional contrast if needed. This opportunity to image without a contrast agent shortens the pathway towards full clinical translation as the regulatory issues and risks associated with contrast agents can be circumvented 44 .
Rapid evaporative ionization mass spectrometry
Intraoperative molecular diagnostics based on mass spectrometry have recently gained attention from the medical field as they offer the possibility of in vivo, in situ and real-time mass spectrometric analysis of tissue 15, 69 .
In combination with electrosurgical devices 49 , rapid evaporative ionization mass spectrometry (REIMS) promises to guide and optimize surgical resection in real time as it is performed within a couple of seconds. Within this time frame, the smoke generated by electrocautery is aspirated through tubing and a chemical analysis takes place, followed by real-time data processing and finally quasi-instant visual feedback. Nevertheless, to maintain this speed, there is the need for validated tissue-specific databases which require time to generate and for a large clinical cohort to account for interindividual variability. When such a database becomes available, it is expected that any tissue can be analysed 15, 45, 47 . In addition, complex molecular signatures can be identified, which can increase the specificity over that achieved with a single biomarker 45 . Although it is not a true 'imaging' technique, REIMS has the potential to improve surgical margins by molecular sampling of margins 70 , comparable to that in Mohs surgery for skin cancer, in which the resected specimen is examined for cancer cells during the procedure 71 .
Discussion
Tumour removal is an incremental and iterative process, so there should also be the possibility to obtain intraoperative images linked to those obtained by initial staging scans 45 . This may require merging more than one modality. Ultrasonography is a well established technique for interventional procedures, but is rarely the choice for definitive staging. In comparison, SPECT and PET may be used for tumour staging, but cannot be utilized during surgery owing to size limits, whereas portable small γ cameras may suffice 11 . For this purpose, a conventional anatomical technique, such as MRI, CT or ultrasonography, can be combined with a biological imaging modality, such as optical or nuclear imaging, with the use of a targeted tracer. Alternatively, a technique used during surgery for (re)orientation can be combined with one used for quality control of the resection cavity or lump assessment (Tables 4-6 ). Another option is the use of a technique with a high penetration depth but somewhat lower resolution complementary to one of the imaging modalities in the endogenous reflectance group to compensate for the loss of resolution. Both options will lead to a more complete overview of the actual situation in a patient. Fig. 4 shows differences between the techniques in relation to depth, resolution and acquisition time 2, 72 . Techniques that are plotted further apart from each other in the figure may gain the most in combination. So far, the biggest challenge remains fusion of the images generated by different techniques, which can lead to a degree of uncertainty; the greater the distance between two modalities in Fig. 4 , the greater the challenge. Over the past decade, imaging has broadened from the conventional anatomical overview to state-of-the-art methods giving a molecular description of structure or function 73 . The overall goal of imaging is to provide a better outcome. It should be noted that better outcome can be defined from different perspectives, that of the patient, surgeon, instrument manufacturer and society, and these may often differ 70 . With intraoperative MRI, for example, surgeons appreciate the fact that they have better visualization and a higher chance of complete tumour resection, but they prefer shorter procedure times and use of intraoperative MRI can increase these by up to 2 h 24, 25 . In addition, a reduction in complications, such as tumour-bed haematoma formation, may be achieved with intraoperative MRI detection 22, 25 . From a manufacturing standpoint, intraoperative MRI is viewed as successful owing to its reputation and competitive benefits from good system performance in an operating room 70 .
For the imaging modalities discussed here, when used in open surgery, the surgeon must look away from the operative field to review the images on a screen; this is not the ideal situation. With augmented reality, the imaging results are projected on to the operative field, which allows visualization of different types of image merged with each other. These images can be obtained before surgery, allowing more detailed planning of the operation beforehand. The major limitation with this approach is the deformation of soft tissue during the surgical procedure, and the orientation of the image display in relation to the surgical field. The application of augmented reality is most promising in the treatment of tumours associated with bone structures 8 . However, the challenges for minimally invasive surgery are shifted to limited depth perception and haptic feedback, leading to a disconnection between the hand and eye 74 .
With augmented reality, a patient-specific virtual model can be created for open or minimally invasive surgery to assist surgeons in maintaining 3D interpretations, as in robotic procedures 8, 75 .
It should be noted that none of the modalities described provide comprehensive medical information. As a result of improvements in conventional imaging modalities, the expectations placed on imaging systems have increased and none are without any limitations 76, 77 . Hybrid or multimodal imaging is commonly employed in diagnostics (such as PET-CT or SPECT) to combine functional and anatomical information.
Is it necessary to know the signal intensity or amount of contrast agent in each cubic centimetre, or is having the signal intensity or amount of contrast agent in arbitrary units per pixel/voxel sufficient? Surgical decisions are generally based on visual interpretation of data, which gives only an impression and does not lead to quantitative results. What data are necessary for a particular medical/clinical outcome? Does improved clinical outcome rely on absolute numbers during surgery? Can these data be generated in sufficient time for the patient/surgeon? Most imaging modalities are unable to provide absolute quantification owing to noise, scattering and motion, or the absence of a standard. All ten modalities reviewed here allow relative quantification, assuming that the signals are independent of the position in the sample and no motion artefacts are present. Although absolute quantification is preferred, particularly in monitoring response to therapy, relative quantification is sufficient in practice and for most other indications. The future of medical imaging is in the transfer of images to data with a high negative power and a focus on sensitivity.
Finally, standardization is necessary to achieve reproducible and reliable information, which makes interinstitutional comparisons feasible and facilitates the implementation of new techniques from one site to another. Standardization is a prerequisite, especially in case of quantification. To achieve images that are intuitive to interpret, reproducibility and reliability are key parameters. Each modality requires technical standardization for both signal acquisition and image reconstruction, and to account for the biological factors associated with the contrast agent and patient heterogeneity. Technical factors can be standardized relatively easily with the use of standard operating protocols and an accurate quality assurance programme, including validated libraries or calibration curves for the contrast agent. As an example, the REMARK (REporting recommendations for tumour MARKer prognostic studies) study gave recommendations on how to report results about tumour markers in a standardized way for assessment of the quality and generalizability for further research 78 . A similar protocol should be developed for imaging and molecular modalities used in surgery.
Each imaging modality has its own strengths, and no single technique will be suitable for all surgical procedures and fields. Strict selection of modalities by cancer type and surgical requirements is required, as well as combining techniques in order to increase visualization and decrease noise. The range of available modalities at differing levels of development makes comparison necessarily qualitative. Eventually, standardization of data across the different imaging and molecular modalities will enable data to be compared in an equipollent manner.
